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ABSTRACT	
BACKGROUND:	 Hypercalcaemia	 is	 rare	 in	 children	 and	 may	 present	 with	 characteristic	
signs/symptoms	 or	 coincidentally	 following	 investigations	 for	 a	 variety	 of	 non-specific	
conditions.	 	The	aetiologies	of	childhood	hypercalcaemia	are	diverse.	Untreated	sustained	
hypercalcaemia	has	serious	clinical	consequences.	However	there	is	 limited	data	regarding	
the	true	frequency	and	aetiologies	of	childhood	hypercalcaemia.		
AIM:	 To	 determine	 the	 frequency	 of	 severe	 childhood	 hypercalcaemia	 in	 routine	 clinical	
practice.	
METHODS:	 The	 laboratory	 database	 was	 searched	 for	 all	 children	 (0-17	 yrs)	 with	 severe	
hypercalacemia	 defined	 as	 non-adjusted	 ≥2.90	 mmol/L	 from	 2007-2012.	 Hypercalcaemia	
was	 categorised	 as	 either	 transient	 (1	 day)	 or	 sustained	 (≥2	 consecutive	 days).		
Retrospective	 analysis	 of	 all	 cases	 of	 sustained	 severe	 hypercalcaemia	 was	 performed	 to	
identify	the	underlying	aetiology.	
RESULTS:	 	 Over	 the	 5	 yr	 period,	 206	 children	were	 identified	 as	 severely	 hypercalcaemic	
≥2.90	 mmol/L	 (0.3%	 all	 61,380	 calcium	 requests).	 Of	 these	 131(63.3%)	 children	 were	
classified	as	having	sustained	hypercalcaemia.	The	frequency	of	severe	hypercalcaemia	was	
highest	 in	neonates	 (42%	of	sustained	cases)	and	was	 inversely	 related	to	age.	Sepsis	was	
the	most	common	aetiology	(24%),	particularly	 in	neonates	where	it	accounted	for	41%	of	
all	 causes	 of	 neonatal	 hypercalcaemia.	 Endocrine	 aetiologies	 included	 congenital	 adrenal	
hyperplasia(CAH)	 (2	 cases),	 fat	 necrosis	 (1),	 Addisons’	 disease	 (2).	 A	 genetic	 cause	 was	
identified	in	3	children	(2	Familial	hypocalciuria	hypercalcaemia,	1	Williams	syndrome.	
CONCLUSION:	 Sustained	 hypercalcaemia	 affects	 1	 in	 500	 children	 in	 a	 general	 hospital	
setting.	The	frequency	was	highest	in	neonates	and	underlying	aetiology	differed	markedly	
with	 age.	 All	 children	 with	 sustained	 hypercalcaemia	 require	 thorough	 investigation	 to	
determine	the	underlying	aetiology	to	ensure	appropriate	management.	
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INTRODUCTION	
Hypercalcaemia	 is	 an	 uncommon	 finding	 in	 children,	 however	 the	 clinical	 significance	 is	
likely	greater	in	younger	patients,	[1].	The	aetiology	of	childhood	hypercalcaemia	is	diverse	
in	comparison	to	adults	where	hyperparathyroidism	and	malignancy	account	for	90%	of	all	
cases,	[2-4].	Furthermore	the	cause	of	childhood	hypercalcaemia	may	be	age-related,	with	
many	cases	suspected	of	having	an	underlying	genetic	origin,	[5].	The	clinical	presentation	is	
often	 insidious	 and	 non-specific	with	 the	most	 frequently	 encountered	 features	 including	
lethargy,	polyuria/polydipsia,	vomiting,	constipation	and	abdominal	and	bone	pains,	[5].	 In	
addition,	 as	 calcium	 is	 often	 not	 included	 in	 local	 routine	 biochemistry	 urea	 and	
electrolyte(U&E)	profiles,	hypercalcaemia	may	go	undiagnosed	particularly	in	children	who	
appear	asymptomatic.		
Normal	 calcium	homeostasis	 is	maintained	 by	 dynamic	 interactions	 between	 parathyroid,	
renal	and	skeletal	 factors,	 [1].	The	principal	calciotrophic	hormonesinfluencing	these	feed-
back	 processes	 are	 parathyroid	 hormone	 (PTH)	 and	 1,25dihydroxyvitamin	 D3,	 the	 active	
metabolite	of	vitamin	D,	[5,6].	Any	factor	disrupting	this	finely	tuned	mechanism	can	have	
major	 significances.	 Untreated	 hypercalcaemia	 of	 any	 cause	 can	 have	 serious	 clinical	
consequences,	 ranging	 in	 severity	 from	 non-specific	 fatigue	 and	 nausea	 to	 renal	
complicationsand	neurological	sequeale,	[6].	
To	date	there	 is	no	consensus	definition	of	hypercalcaemia	 in	paediatrics	 [1,8].	This	 factor	
may	 help	 explain	 thelimitedreliable	 data	 on	 the	 relative	 frequency	 and	 the	 different	
aetiologies	causing	hypercalcaemia	in	childhood.		
The	principal	aim	of	this	retrospective	study	was	to	determine	the	frequency	and	categorise	
the	 different	 causes	 of	 childhood	 hypercalcaemiain	 a	 tertiary	 hospital	 environment.	 In	
addition,	we	 sought	 to	 determine	 if	 appropriate	 biochemical	 parameters	were	 requested	
following	identification	of	hypercalcaemia.	
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METHODS	
Laboratory	 databases	 (Royal	 Hospital	 for	 Sick	 Children	 (RHSC),	 Glasgow)	 were	 searched	
retrospectively	for	all	total	(unadjusted)	calcium	requests	on	children	(<17	yrs)	over	a	5	year	
period	 (2007-2011).	During	 this	 period,	 calcium	was	 part	 of	 the	 routine	 biochemistryurea	
and	 electrolyte	 (U&E)	 profile.	 Normal	 calcium	 reference	 intervals	 derived	 from	 healthy	
infants	and	children	were	defined	as	2.2-2.7	mmol/L	for	 infants	(<1yr)	and	2.2-2.6	mmol/L	
for	children	(1-18yr)	[7,8].	Therefore,	hypercalcaemia	was	defined	as	mild(≥2.9-3.1mmol/L);	
moderate	 (≥3.2-3.5mmol/L)	 or	 severe(>3.5mmol/L)	 and	 categorised	 as	 transient(1day)	 or	
sustained(≥2	 consecutive	 days).	 Hospital	 information	 systems	 and	 clinical	 records	 were	
reviewed	 to	 determine	 where	 possible	 the	 aetiology	 of	 sustained	 hypercalcaemia	 and	
modalities	 of	 treatment	 implemented.	 	 The	 causes	 of	 hypercalcaemia	 were	 broadly	
categorised	 as	 endocrine,	 renal,	 oncological,	 iatrogenic	 (cardiac),	 suspected	 sepsis	
(determined	by	 clinical	 review)	 and	other	 causes	of	 hypercalcaemia.	 Plasma	 total	 calcium	
was	measured	by	Arsenazo	III	methodology	on	the	Abbott	Architect	ci8000,	with	inter	and	
intra	 assay	 imprecisions	 of<2.0%	 and	 <1.50%	 respectively.	 Where	 available	 other	 bone-
related	 biochemical	 parameters	 including	 phosphate,	 alkaline	 phosphatase	 (ALP),	 PTH,	
Vitamin	D	 and	 urinary	 calcium/creatinine	 ratio	were	 documented	with	 the	 corresponding	
elevated	calcium	result.Thisretrospective	laboratory	audit	aimed		to	identify	the	number	of	
cases,	 causes	and	appropriate	 investigation	of	hypercalcaemia	 in	a	paeditatric	population.	
As	this	study	was	part	of	a	health	service	evaluation,	ethical	approval	was	not	required.	
RESULTS	
Of	 the	 61,380	 children	who	 had	 ≥1	 calcium	 requests	 over	 the	 5	 year	 period,	 206(0.33%)	
were	 identified	 as	 hypercalcaemic	 with	 a	 total	 calcium	 ≥2.90mmol/L.	 165(0.27%)children	
were	classified	as	having	a	mild	hypercalcaemia,	with	25(0.04%)	children	defined	moderate	
and	 16(0.02%)	 defined	 as	 severely	 hypercalcaemic.	 Of	 the	 206	 children	 identified,	
131(63.6%)	 were	 classified	 as	 having	 sustained	 hypercalcaemia	 (elevated	 calcium	 for	 ≥2	
consecutive	 days),	 giving	 an	 overall	 frequency	 of	 1	 case	 per	 500	 children.	 The	 cause	 of	
sustained	hypercalcaemia	defined	under	broad	categories	according	to	the	age	is	outlined	in	
Table	1.	
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Age	 Endocrine	 Renal	 Oncological	 Iatrogenic	
(Cardiac)	
Sepsis	 Other	 Total	
<28days	 1	 3	 2	 11	 23	 15	 55	
28d–	1yr	 2	 3	 1	 10	 5	 11	 32	
1-5yr	 2	 9	 5	 0	 1	 1	 18	
6-12yr	 2	 7	 3	 0	 3	 1	 16	
13-17yr	 2	 5	 1	 2	 0	 0	 10	
Total	 9	 27	 12	 23	 32	 28	 131	
	
Table	1.Aetiology	of	hypercalcaemia	according	to	age.	
The	 frequency	 of	 sustained	 hypercalcaemia	 was	 highest	 in	 neonates	 (55/131;	 42%	 of	 all	
sustained	cases)	and	was	inversely	related	to	age	(figure	1).		Suspected	neonatal	sepsis	was	
the	 single	 commonest	 cause	 (23/131;	24%)	of	hypercalcaemia.	 In	 the	majority	of	 children	
>1yr,	 the	 cause	 of	 sustained	 hypercalcaemia	 due	 to	 their	 underlying	 condition	 (renal;	
tertiary	 hyperparathyroidism	 or	 oncological),	 or	 iatrogenic	 relating	 to	 their	 treatment	
regimen	(e.g.	cardiac	aetiologies).	28(21.4%)	cases	were	categorised	as	“other”	with	surgery	
(neuro-	 or	 gastro-)	 being	 the	 highest	 single	 cause	 (11	 cases).	 A	 primary	 respiratory,	
metabolic	or	gastroenterological	cause	was	implicated	in	7	cases.	Prematurity	was	thought	
the	 likely	 aetiology	 in	 a	 further	 4	 cases.	 The	 underlying	 cause	 of	 2	 cases	 of	 sustained	
hypercalcaemia	remains	unknown	but	is	likely	multi-factorial	with	a	both	children	having	a	
number	of	co-morbidities.		
Conditions	associated	with	sustained	hypercalcaemia	encountered	by	the	endocrine	service	
included	 3	 cases	 of	 adrenal	 insufficiency,	 2	 cases	 of	 familial	 hypocalciuric	 hypercalcaemia	
(FHH)	 and	 individual	 cases	 of	 idiopathic	 “unknown”	 hypercalcaemia,	 subcutaneous	 fat	
necrosis	 and	 Williams-Beuren	 Syndrome.	 One	 child	 had	 numerous	 pathologies	 on	
presentation	including	thyrotoxicosis	and	nephrocalcinosis.		
In	 terms	 of	 severity	 of	 hypercalcaemia,	 the	 majority	 111/131	 (84.7%)	 of	 children	 were	
classified	as	mild(2.9-3.1mmol/L)	with	13(9.9%)	identified	as	moderate(3.2-3.5	mmol/L)	and	
7(5.4%)	severe(>3.5	mmol/L)(Table	2).		
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Age	 Mild	
(≥2.9-3.1	mmol/l)	
Moderate	
(3.2-3.5	mmol/L)	
Severe	
(>3.5	mmol/L)	
Total	
<28days	 53	 1	 1	 55	
28days	–	1yr	 29	 1	 2	 32	
1-5yr	 9	 6	 3	 18	
6-12yr	 11	 4	 1	 16	
13-17yr	 9	 1	 0	 10	
Total	 111	 13	 7	 131	
	
Table	2.	Severity	of	hypercalcaemia	classified	by	age	
There	was	no	correlation	between	underlying	cause	and	severity	of	hypercalcaemia	with	2	
cases	of	severe	hypercalcaemia	due	to	management	following	cardiac	surgery	(iatrogenic),	2	
due	to	renal	complications	and	3	endocrine	related	conditions	
Algorithms	 for	 investigating	 hypercalcaemia	 frequently	 include	 analysis	 of	 PTH,	 vitamin	D	
and/or	urinary	calcium/creatinine	 ratios	 to	aid	 the	differential	diagnosis,	 [1,5].	Of	 the	131	
children	 identified	 as	 having	 sustained	 hypercalcaemia,	 PTH	 alone	 was	 analysed	 in	 43	
(32.8%)	whereas	12/131	(9.2%)	had	both	PTH	and	vitamin	D.	Vitamin	D	deficiency	(i.e.<25	
nmol/L)	was	noted	 in	2	patients,	3	were	classified	as	vitamin	D	 insufficient	(25-50	nmol/L)	
with	 the	 remaining	 7	 patients	 have	 sufficient	 vitamin	 D	 concentrations	 (>50	 nmol/L).	 No	
children	had	vitamin	D	intoxication,	a	known	cause	of	hypercalcaemia.	Only	11/131	(8.4%)	
patients	had	PTH,	vitamin	D	and	urinary	calcium/creatinine	results,	the	underlying	aetiology	
of	each	patient	is	showing	in	Table	3.	There	was	no	correlation	between	age,	severity,	cause,	
duration	 of	 hypercalcaemia	 or	 requesting	 speciality	 and	 performance	 of	 additional	
biochemical	tests	(i.e.	PTH,	vitamin	D,	urinary	calcium/creatinine	ratio).		
Severity	of	Hypercalcaemia	 Number	of	patients	 Aetiology	
Mild		(≥2.9-3.1	mmol/l)	 4	 Iatrogenic	(cardiac),	oncology	
“other”	x2	
Moderate	(3.2-3.5	mmol/L)	 3	 Oncology,	endocrine	x	2	
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Severe		(>3.5	mmol/L)	 4	 Iatrogenic	(cardiac),	endocrine	x	3		
	
Table	3.	The	aetiology	of	hypercalcaemia	in	children	who	underwent	comprehensive	biochemical	
assessments	(PTH,	Vitamin	D	and	urinary	calcium/creatinine),	categorised	according	to	severity.	
	
DISCUSSION	
Hypercalcaemia	 is	 an	uncommon	 finding	 in	paediatrics.	 The	often	non-specific	 symptoms,	
diverse	 age-related	 aetiologies	 and	 lack	 of	 calcium	 in	 many	 routine	 biochemistry	 U&E	
profiles	may	delay	diagnosis	and	implementation	of	appropriate	treatments.	Consequently	
the	 true	 frequency	 of	 childhood	 hypercalcaemia	 in	 a	 tertiary	 hospital	 setting	 is	 to	 date	
unclear.		
The	current	retrospective	study	which	included	over	61,000	children,	illustrated	the	rarity	of	
hypercalcaemia	 (>2.9	 mmol/L)	 with	 only	 203	 (0.33%)	 cases	 over	 a	 5yr	 period.	 Sustained	
hypercalcaemia,	i.e.	hypercalcaemia	over	≥2	consecutive	days,	affected	1	in	500	children	in	
a	general	hospital	setting.		
The	 underlying	 aetiologies	 of	 sustained	 hypercalcaemia	 were	 diverse,	 ranging	 from	 renal	
failure	 (e.g.	 tertiary	 hyperparathyroidism)	 and	 malignancy	 to	 iatrogenic	 causes	 including	
Total	Parental	Nutrition	(TPN),	[5].	Suspected	neonatal	sepsis,	defined	by	clinical	judgement	
was	the	single	most	common	cause	(41%)	of	hypercalcaemia	however	sepsis/infection	alone	
is	not	routinely	included	as	one	of	the	common	causes	of	hypercalcaemia	in	neonates	and	
infants,	 [1,9].	The	possible	mechanisms	causing	the	sustained	hypercalcaemia	may	 include	
extra-renal	 production	 of	 1,25(OH)2D	 by	 infiltrating	 macrophages,	 [1],	 and/or	 release	 of	
cytokines	 such	as	 interleukin	6	 (IL-6)	 increasing	osteoclastic	 activity,	 thus	bone	 resorption	
and	calcium	release,	[5].	
Only	nine	cases	of	sustained	hypercalcaemia	were	categorised	as	endocrine-related,	causes	
of	which	 included	congenital	adrenal	hyperplasia	 (CAH)(2),	autoimmune	Addisons’	disease	
(1)	and	subcutaneous	fat	necrosis	(1).	Hypercalcaemia	due	to	a	genetic	cause	was	identified	
in	 three	 children.	 A	 heterozygous	 in-activating	 mutation	 in	 the	 calcium	 sensing	 receptor	
(CaSR)	 causing	 familial	 Hypocalciuric	 hypercalaemia	 (FHH)	 was	 found	 in	 two	 children.	
Diagnosis	of	Williams-Beuren	was	confirmed	by	the	presence	of	a	deletion	on	chromosome	
8	
	
7q11.23,	 [10].	 	 The	 underlying	 cause	 of	 one	 case	 remains	 unknown.	 This	 patient	 has	
presented	 to	 A&E	 on	 at	 least	 3	 separate	 occasions	 over	 the	 5	 year	 period	 with	 a	 short	
history	of	non-specific	symptoms	including	constipation,	weight	loss	and	leg	pain.	On	each	
occasion,	 the	 severe	 hypercalcaemia	 (total	 calcium	 ranging	 from	 4.9-5.6	 mmol/L)	 was	
successfully	 treated	 with	 IV	 fluids,	 diuretics	 (Frusemide)	 and	 bisphosphonates	
(Pamidronate),	 [5,11].	 The	 patient	 was	 discharged	 on	 a	 low	 calcium	 diet	 and	 vitamin	 D	
(Dalavit)	and	remained	asymptomatic	for	a	period	of	1-2	years	before	re-presenting.	Genetic	
studies,	 imaging	 (ultra-sound,	 chest	 x-ray,	 sestamibi	 scan)	 and	 biochemistry	
(catecholamines,	 tumour	 markers,	 ACE,	 PTH-rP)	 were	 all	 normal.	 	 Further	 genetic	
investigations	are	in	progress.	
The	relationship	between	age	of	child	and	frequency	of	hypercalcaemia	has	not	previously	
been	 reported.	 66%	 of	 all	 cases	 of	 sustained	 hypercalcaemia	 in	 this	 study	 were	 ≤1	 yr,	
whereas	 only	 7.6%	were	 adolescents	 (13-17yrs).	 There	 is	 the	 potential	 that	 the	 reported	
age-related	 phenomenom	 was	 subject	 to	 some	 population	 bias	 due	 to	 the	 specialist	
neonatal	 facilities	 provided	 in	 the	 study	 hospital.	 Of	 note,	 22.8%	 of	 all	 calcium	 requests	
were	 from	 children	 <1	 yr.	 Furthermore	 it	 is	 possible	 that	 some	 adolescents	 with	 chronic	
conditions	 such	 as	 renal	 failure	 may	 have	 been	 transitioned	 to	 adult	 physicians	 for	 the	
management	of	disease	therefore	would	not	be	identified	in	this	study	cohort.		
There	 is	 a	 clear	 age-related	 aetiological	 phenomenon	 of	 hypercalcaemia	 with	 sepsis	 and	
“other”	 esoteric	 causes	 accounting	 for	 69%	 of	 all	 cases	 of	 sustained	 hypercalcaemia	 in	
neonates.	 In	contrast,	no	cases	of	sepsis	or	“other”	esoteric	causes	were	 identified	as	 the	
primary	 origin	 of	 sustained	 hypercalcaemia	 in	 adolescents	 (13-17yrs).	 This	 age-related	
finding	 supports	 those	 of	 Lietmanet	 al,	 [1],	 whose	 study	 propose	 differential	 diagnostic	
tables	 for	 infants	 <2yr	 and	 children.	 Interestingly,	 in	 the	 study	 by	 Lietmanet	 al,	 [1],sepsis	
alone	was	not	included	as	a	potential	cause	of	hypercalcaemia	in	any	age	group,	suggesting	
it	 may	 not	 be	 considered	 as	 the	 underlying	 cause	 of	 hypercalcaemia	 and	 may	 result	 in	
further	unnecessary	 investigations.	A	further	 interesting	finding	in	this	study	population	of	
>61,000	 children	 was	 there	 were	 no	 cases	 of	 primary	 hyperparathyroidism,	 one	 of	 the	
principal	 causes	 of	 hypercalcaemia	 in	 adults.	 This	 may	 be	 due	 to	 the	 limited	 number	 of	
children	who	had	both	calcium	and	PTH	measured	 (43/131	children,	32.8%).	 	Despite	 this	
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limitation,	 it	 highlights	 the	 importance	 of	 appreciating	 paediatrics/children	 as	 a	 speciality	
when	considering	a	differential	diagnosis	of	hypercalcaemia.	
Additional	 biochemical	 tests	 are	 frequently	 suggested	 when	 investigation	 the	 potential	
cause	 of	 hypercalcaemia,	 [1,5].	 The	 reasons	 why	 only	 (32.8%)	 of	 children	 with	 sustained	
hypercalcaemia	had	PTH	requested	remains	unclear	however	potential	factors	may	include	
the	underlying	 cause	of	 hypercalcaemia	 already	being	 known	by	 the	 requesting	 physician	
(i.e.	tertiary	hyperparathyroidism	or	iatrogenic)therefore	additional	investigations	were	not	
required	 for	 appropriate	 patient	 management	 and/or	 the	 additional	 sample	 volume	
required	 for	 this	 test.	 The	 lack	 of	 vitamin	D	 requests	 noted	 in	 the	 study	 population,	 only	
9.2%	of	all	cases,	may	relate	to	 lack	of	availability	of	Vitamin	D	analysis	on-site	during	the	
time	 of	 the	 audit	 (2007-2012).	 Furthermore,	 the	 nature	 of	 the	 methodology	 used	 in	 at	
referral	hospital	required	a	pre-analytical	solid	phase	extraction	step,	thus	a	relatively	large	
sample	 volume	 (300	 µl).	 As	 numerous	 analytes	 are	 often	 requested	 on	 single,	 small	
paediatric	samples	obtaining	sufficient	volume	for	send-away	tests	is	a	continual	problem.		
	
CONCLUSION	
This	 study	 of	 >61,000	 calcium	 requests	 demonstrated	 that	 sustained	 childhood	
hypercalcaemia	 is	 rare	 with	 a	 frequency	 of	 2.1	 cases	 per	 1,000.	 Hypercalcaemia	 was	
inversely-related	to	age,	with	the	highest	occurrencein	neonates.	The	underlying	aetiologies	
differ	 markedly	 with	 age	 with	 neonatal	 sepsis	 being	 the	 single	 most	 common	 cause.	
Although	 many	 of	 these	 conditions	 are	 uncommon,	 it	 is	 important	 all	 children	 with	
sustained	 hypercalcaemia,	 where	 the	 condition	 is	 not	 associated	 with	 their	 medical	
treatment,receivethorough	and	expert	investigation	to	determine	the	underlying	aetiology.	
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